Efficacy and Safety of Dual GLP-1/Glucagon Receptor Agonism in Overweight and Obesity: A Class-Specific Systematic Review and Meta-Analysis. (PubMed, Diabetes Obes Metab) - Oct 1, 2026 - "Dual GLP-1/GCGR agonists produce meaningful weight loss and metabolic improvements with acceptable short-term safety, though longer head-to-head trials are needed to confirm durability and cardiovascular safety."
Journal • Retrospective data • Cardiovascular • Genetic Disorders • Obesity
|
|
Amir Hamza Khan; Aqsa Ali; Bilal Wazir Khan; Dur-E-Najaf Ali; Faiza Bakhash; Farah Ibrahim; Fatima Sarwar; Huma Hassan; Humna Abid; Ihsan Qamar; Kashaf Mustafa; Maham Ali; Malik Muhammad Nasr Fayyaz; Muhammad Maaz Amjad; Muhammad Mustafa Khan; Muhammad Yaseen; Safwan Masaud Mian; Sami Ullah
|